Clinical trial
A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in the Treatment of Symptoms of Vulvovaginal Atrophy in Postmenopausal Women
NCT01455597 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in the Treatment of Symptoms of Vulvovaginal Atrophy in Postmenopausal Women
- Lead sponsor
- Warner Chilcott
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 20, 2011
- Completion date
- December 3, 2012
- Enrollment
- 309 (actual)
- Sites
- 64
Conditions
As the registry lists them; a condition with its own page is linked.
vulvovaginal atrophy